Not Medicare Enrolled

Dr. Katherine Charrier, OD

Optometrist · Spring, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2827 WATERBEND CV STE 100, Spring, TX 77386
7133490224
In practice since 2017 (8 years)
NPI: 1972027530 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Charrier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Charrier? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Charrier

Dr. Katherine Charrier is an optometrist in Spring, TX, with 8 years in practice. Based on federal Medicare data, Dr. Charrier performed 789 Medicare services across 633 unique beneficiaries.

Between the years covered by Open Payments, Dr. Charrier received a total of $2,267 from 23 pharmaceutical and/or device companies across 93 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Charrier is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice▲ Top 14% volume in TX$ $2,267 industry payments

Medicare Practice Summary

Medicare Utilization ↗
789
Medicare services
Top 14% in TX for optometrist
633
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~99 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Comprehensive eye exam, established patient241$83$233
Visual field test, extended117$44$122
Optic nerve imaging (OCT scan)110$24$95
Eye exam, established patient, focused109$64$161
Retinal imaging (OCT scan)102$26$90
Comprehensive eye exam, new patient48$83$282
Corneal topography and eye depth measurement25$27$180
Retinal photography (fundus photo)25$26$140
Ultrasound scan of cornea to determine thickness12$7$29
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,267
Total received (2018-2024)
Avg $324/year across 7 years
Top 23% in TX for optometrist
23
Companies
93
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,267 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$308
2023
$292
2022
$356
2021
$442
2020
$355
2019
$262
2018
$253

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb, a division of Bausch Health US, LLC
$564
Allergan Inc.
$178
Allergan, Inc.
$151
Sun Pharmaceutical Industries Inc.
$145
Dompe US, Inc.
$136
Novartis Pharmaceuticals Corporation
$132
Oyster Point Pharma, Inc.
$126
Apellis Pharmaceuticals, Inc.
$119
ABBVIE INC.
$102
SUN PHARMACEUTICAL INDUSTRIES INC.
$92
Shire North American Group Inc
$69
Horizon Therapeutics plc
$66
Bausch & Lomb Americas Inc.
$65
Kala Pharmaceuticals, Inc.
$54
Eyevance Pharmaceuticals LLC
$52
Akorn Operating Company LLC
$46
Aerie Pharmaceuticals, Inc.
$39
Mallinckrodt Hospital Products Inc.
$33
BIOTISSUE HOLDINGS, INC.
$24
Rayner Intraocular Lenses Limited
$21
BioTissue Holdings, Inc.
$20
Mallinckrodt Enterprises LLC
$18
Johnson & Johnson Surgical Vision, Inc.
$14
Top 3 companies account for 39.3% of total payments
Associated products mentioned in payments ›
ACTHAR · COMBIGAN · Cequa · DUREZOL · ENVISTA · Flarex · INVELTYS · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · OXERVATE · Omidria · PROKERA · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · TEPEZZA · TYRVAYA · VUITY · VYZULTA · XIIDRA · ZYLET · Zioptan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $287 per 100 Medicare services performed
Looking for a optometrist in Spring?
Compare optometrists in the Spring area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
519
Per 100K population
79.3
County median income
$97,266
Nearest hospital
THE WOODLANDS SPECIALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Charrier is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Charrier experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Charrier performed 241 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Charrier receive payments from pharmaceutical companies?
Yes. Dr. Charrier received a total of $2,267 from 23 companies across 93 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Charrier's costs compare to other optometrists in Spring?
Dr. Charrier's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Charrier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →